Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.49 DKK 0.4%
Market Cap: 640.2m DKK
Have any thoughts about
Bioporto A/S?
Write Note

Bioporto A/S
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bioporto A/S
Other Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Bioporto A/S
CSE:BIOPOR
Other Receivables
kr8.9m
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Other Receivables
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Other Receivables
kr10.7m
CAGR 3-Years
-34%
CAGR 5-Years
-6%
CAGR 10-Years
1%
Ascendis Pharma A/S
NASDAQ:ASND
Other Receivables
€17.3m
CAGR 3-Years
-5%
CAGR 5-Years
41%
CAGR 10-Years
56%
B
Bavarian Nordic A/S
CSE:BAVA
Other Receivables
kr29.6m
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
10%
Saniona AB
STO:SANION
Other Receivables
kr8.3m
CAGR 3-Years
4%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
No Stocks Found

Bioporto A/S
Glance View

Market Cap
640.2m DKK
Industry
Biotechnology

Bioporto A/S engages in the provision of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL) ELISA kit, which offers monoclonal MBL antibodies that are responsible for the activation of immune response; Antibodies, including monoclonal antibodies used in a range of research areas, such as microbiology, biomarkers, peptide hormones and plasma proteins; and Activated Protein C with Protein C Inhibitor Complex (APC-PCI), a biomarker applied to patients with sepsis and thrombotic and hemostatic disorders. In addition, the Company is a parent of BioPorto Diagnostics A/S.

BIOPOR Intrinsic Value
1.3 DKK
Overvaluation 13%
Intrinsic Value
Price

See Also

What is Bioporto A/S's Other Receivables?
Other Receivables
8.9m DKK

Based on the financial report for Jun 30, 2024, Bioporto A/S's Other Receivables amounts to 8.9m DKK.

What is Bioporto A/S's Other Receivables growth rate?
Other Receivables CAGR 5Y
7%

Over the last year, the Other Receivables growth was -9%.

Back to Top